Epidemiologia (Feb 2022)

Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study

  • Salvador Domènech-Montoliu,
  • Joan Puig-Barberà,
  • Maria Rosario Pac-Sa,
  • Paula Vidal-Utrillas,
  • Marta Latorre-Poveda,
  • Alba Del Rio-González,
  • Sara Ferrando-Rubert,
  • Gema Ferrer-Abad,
  • Manuel Sánchez-Urbano,
  • Laura Aparisi-Esteve,
  • Gema Badenes-Marques,
  • Belen Cervera-Ferrer,
  • Ursula Clerig-Arnau,
  • Claudia Dols-Bernad,
  • Maria Fontal-Carcel,
  • Lorna Gomez-Lanas,
  • David Jovani-Sales,
  • Maria Carmen León-Domingo,
  • Maria Dolores Llopico-Vilanova,
  • Mercedes Moros-Blasco,
  • Cristina Notari-Rodríguez,
  • Raquel Ruíz-Puig,
  • Sonia Valls-López,
  • Alberto Arnedo-Pena

DOI
https://doi.org/10.3390/epidemiologia3010006
Journal volume & issue
Vol. 3, no. 1
pp. 49 – 67

Abstract

Read online

In October 2020, we conducted a population-based prospective cohort study to determine post-COVID-19 complications, recovery, return to usual health, and associated risk factors in 536 cases of COVID-19 outbreak in Borriana (Spain) by administering an epidemiological questionnaire via phone interviews. A total of 484 patients participated (90.3%), age mean 37.2 ± 17.1 years, and 301 females (62.2%). Mild illness was the most common COVID-19 manifestation. After six months, 160 patients (33.1%) suffered at least one complication post-COVID-19, and 47 (29.4%) of them sought medical assistance. The most frequent persistent symptoms were hair loss, fatigue, loss of smell or taste, and headache. Risk factors associated with a complication were female sex (adjusted relative risk, [aRR] = 1.93 95% confidence interval [CI] 1.41–2.65), age 35 years and above (aRR = 1.50 95% CI 1.14–1.99), B blood group (aRR = 1.51 95% CI 1.04–2.16), current smoker (RR = 1.61 95% CI 1.02–2.54), and at least a COVID-19 exposure (aRR = 2.13 95% CI 1.11–4.09). Male sex, age younger than 35 years, and low COVID-19 exposures were associated with better recovery and return to usual health. A third of patients presented persistent symptoms compatible with the long-COVID-19 syndrome. In conclusion, an active medical follow-up of post-COVID-19 patients must be implemented.

Keywords